{{Rsnum
|rsid=10145182
|Gene=NIN
|Chromosome=14
|position=50809291
|Orientation=plus
|GMAF=0.2328
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=NIN
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 5.3 | 60.2 | 34.5
| HCB | 3.7 | 17.6 | 78.7
| JPT | 0.0 | 23.9 | 76.1
| YRI | 4.1 | 27.2 | 68.7
| ASW | 5.3 | 28.1 | 66.7
| CHB | 3.7 | 17.6 | 78.7
| CHD | 0.9 | 19.3 | 79.8
| GIH | 12.9 | 35.6 | 51.5
| LWK | 4.5 | 22.7 | 72.7
| MEX | 1.7 | 39.7 | 58.6
| MKK | 3.8 | 25.6 | 70.5
| TSI | 8.8 | 48.0 | 43.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=20056645
|Title=Association of mitotic regulation pathway polymorphisms with pancreatic cancer risk and outcome
|OA=1
}}

{{PMID Auto
|PMID=20508983
|Title=Centrosome-related genes, genetic variation, and risk of breast cancer
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}